Nordson Corp Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
10.6%projected annual EPS growth
Analyst Coverage
7analysts covering
FY Revenue (est.)
$3Bnext fiscal year
FY EPS (est.)
$11.59next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q4 Fiscal 2026 Earnings Release | 16 Dec 2026 |
| Q1 Fiscal 2027 Earnings Release | 18 Feb 2027 |
| Q2 Fiscal 2027 Earnings Release | 24 May 2027 |
Monitoring Framework
Key Performance Indicators
Organic Sales Growth Quarterly700.0%Target: 6% to 8% (Ascend Strategy)
EBITDA Margin Quarterly3,200.0%Target: Leading margins (Ascend Strategy)
Free Cash Flow Conversion Rate Quarterly10,000.0%Target: Over 100% of net income
Watch Items
- Advanced Technology Solutions (ATS) Segment Backlog and Order MomentumTrigger: Slowing order entry or backlog contraction below prior year levelsAction: Re-evaluate full-year revenue projections and assess semiconductor/electronics cycle durability.
- Medical and Fluid Solutions (MFS) Segment EBITDA Margin CompressionTrigger: EBITDA margin decline due to persistent product start-up headwinds or regulatory material changesAction: Monitor operational remediation progress and adjust segment margin expectations.
- Inflationary Pressures and Input Cost IncreasesTrigger: Gross margin compression below historical 55% baselineAction: Analyze pricing power effectiveness and evaluate cost-saving initiatives under the Nordson Business System (NBS) Next framework.
Research as of 2 Sep 2026